32 results
DEF 14A
NRIX
Nurix Therapeutics Inc
25 Mar 21
Definitive proxy
6:03am
industry and his scientific background and training.
Jeffrey Tong, Ph.D., has served as a member of our board of directors since February 2018. Dr. Tong … training and qualifications and the skills and experience he has developed during his extensive career in the life sciences industry.
Lori A. Kunkel, M.D
S-1
EX-10.8
lj6uhq
2 Jul 20
IPO registration
4:04pm
DRS/A
EX-10.8
uvxqcesjtt8haj 1ucm
10 Jun 20
Draft registration statement (amended)
12:00am
424B4
wkzeyul3
5 Mar 21
Prospectus supplement with pricing info
4:07pm
DRS
jrrf2
22 Feb 21
Draft registration statement
12:00am
DRS/A
u3yb0ux0q1552yfdyms
10 Jun 20
Draft registration statement (amended)
12:00am
424B4
o9b s304vkw1fy5
24 Jul 20
Prospectus supplement with pricing info
4:06pm
DRS
d1k57m e2k
5 May 20
Draft registration statement
12:00am
S-1
ea3z76gtl z3e
2 Jul 20
IPO registration
4:04pm
S-1
EX-10.10
wwxasjpd99 wsq
2 Jul 20
IPO registration
4:04pm
DRS
EX-10.10
ifhf23zxtj
5 May 20
Draft registration statement
12:00am